Transcriptomic and ChIP|sequence interrogation of EGFR signaling ...

Transcriptomic and ChIP-sequence interrogation of EGFR signaling ...

The Human Epidermal Growth Factor Receptor (EGFR/HER1) can be activated by several ligands including Transforming Growth Factor alpha ...

Transcriptomic and ChIP-sequence interrogation of EGFR signaling ...

ArticlePDF Available. Transcriptomic and ChIP-sequence interrogation of EGFR signaling in HER2+ breast cancer cells reveals a dynamic chromatin landscape and ...

Transcriptomic and ChIP-sequence interrogation of EGFR signaling ...

Transcriptomic and ChIP-sequence interrogation of EGFR signaling in HER2+ breast cancer cells reveals a dynamic chromatin landscape and S100 genes as targets.

Table 2 Summary of number of peaks in each ChIP-seq

Table 2 Summary of number of peaks in each ChIP-seq. From: Transcriptomic and ChIP-sequence interrogation of EGFR signaling in HER2+ breast cancer cells ...

Additional file 2: of Transcriptomic and ChIP-sequence interrogation ...

Additional file 2: of Transcriptomic and ChIP-sequence interrogation of EGFR signaling in HER2+ breast cancer cells reveals a dynamic chromatin landscape ...

Additional file 4: of Transcriptomic and ChIP-sequence interrogation ...

Additional file 4: of Transcriptomic and ChIP-sequence interrogation of EGFR signaling in HER2+ breast cancer cells reveals a dynamic chromatin landscape ...

Vadgama, Jaydutt | Profiles RNS

Transcriptomic and ChIP-sequence interrogation of EGFR signaling in HER2+ breast cancer cells reveals a dynamic chromatin landscape and S100 genes as targets.

RNA-seq analysis reveals significant effects of EGFR signalling on ...

Using RNA-sequencing, we analysed the whole transcriptome of MSCs stimulated with TGFα. We identified 1,640 highly differentially regulated genes: 967 genes up- ...

Single-cell transcriptomics uncovers EGFR signaling-mediated ...

Here, using a single-cell RNA sequencing method, Quartz-Seq2, we analyzed the gene expression dynamics of progenitor cell differentiation toward ...

Transcriptomic changes underlying EGFR inhibitor resistance in ...

ScRNA-seq and bulk-RNA sequencing were performed to identify transcriptomic ... In this way, LCN2 upregulation may serve to salvage EGFR signaling ...

Connection | Profiles RNS

Search Result Details ; Academic Article, Transcriptomic and ChIP-sequence interrogation of EGFR signaling in HER2+ breast cancer cells reveals a dynamic ...

Interrogating Estrogen Receptor α Signaling in Breast Cancer by ...

Transcriptomic and ChIP-sequence interrogation of EGFR signaling in HER2+ breast cancer cells reveals a dynamic chromatin landscape and S100 genes as targets.

EGFR in Cancer: Signaling Mechanisms, Drugs, and Acquired ...

Transcriptomic and ChIP-sequence interrogation of EGFR signaling in HER2+ breast cancer cells reveals a dynamic chromatin landscape and S100 genes as ...

Proteomic Interrogation of Human Chromatin Protein States ...

Transcriptomic and ChIP-sequence interrogation of EGFR signaling in HER2+ breast cancer cells reveals a dynamic chromatin landscape and S100 genes as targets.

H3K18ac and H3K27ac were mapped post EGF treatment. a EGF ...

EGF upregulates S100 gene family. a Bar graphs are log2 ratios of... Transcriptomic and ChIP-sequence interrogation of EGFR signaling in HER2+ breast cancer ...

In Silico Transcriptome-based Screens Identify Epidermal Growth ...

scRNA-seq analysis of EGFR signaling in adult mouse cochleae. (A) UMAP plot of the whole P28 C57/Bl6 cochlea dataset. (B) Stacked violin ...

Single-Cell Analysis Reveals Transcriptomic Features of Drug ...

3), consistent with ECM1 marking a minor population of cancer cells in most EGFR-mutant lung cancers. Top Pathway Changes That Characterize DTPs ...

Epidermal Growth Factor Receptor Inhibition Reverses Cellular and ...

We also used RNA sequencing (RNA-seq) and transcriptomic ... To test the functional role of EGFR signaling in HX, we used a ...

Transcriptome analysis reveals significant effects of EGFR signaling ...

Abstract. Mesenchymal stem cell (MSCs) are recruited by developing tumors, where MSCs release factors that enhance tumor cell proliferation ...

A Targetable EGFR-Dependent Tumor-Initiating Program in Breast ...

... signaling pathway members could not explain the exceptional response to EGFR inhibition. ... EGFRhi and EGFRlo cells were interrogated ...